Hamoda H - Search Results

1

Hormone replacement therapy: changes in prescribing practice.

Davies M, Hamoda H; British Menopause Society Medical Advisory Council. Davies M, et al. Among authors: hamoda h. BMJ. 2019 Feb 11;364:l633. doi: 10.1136/bmj.l633. BMJ. 2019. PMID: 30745316 No abstract available.

2

Letters to the editor.

Marsden J, Hamoda H; British Menopause Society Medical Advisory Council. Marsden J, et al. Among authors: hamoda h. Ann Oncol. 2019 Aug 1;30(8):1393-1394. doi: 10.1093/annonc/mdz144. Ann Oncol. 2019. PMID: 31070707 Free article. No abstract available.

3

A cross-sectional national questionnaire survey assessing the views of members of the British Menopause Society on the management of patients with unscheduled bleeding on hormone replacement therapy.

Abdullahi Idle S, Panay N, Hamoda H. Abdullahi Idle S, et al. Among authors: hamoda h. Post Reprod Health. 2021 Sep;27(3):159-165. doi: 10.1177/20533691211024415. Epub 2021 Jul 1. Post Reprod Health. 2021. PMID: 34192961

4

Looking at HRT in perspective.

Hamoda H, Moger S. Hamoda H, et al. BMJ. 2022 Jun 15;377:o1425. doi: 10.1136/bmj.o1425. BMJ. 2022. PMID: 35705206 No abstract available.

5

Hormone replacement therapy - Current recommendations.

Vigneswaran K, Hamoda H. Vigneswaran K, et al. Among authors: hamoda h. Best Pract Res Clin Obstet Gynaecol. 2022 May;81:8-21. doi: 10.1016/j.bpobgyn.2021.12.001. Epub 2021 Dec 14. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35000809 Review.

6

The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency.

Hamoda H; British Menopause Society and Women’s Health Concern. Hamoda H, et al. Post Reprod Health. 2017 Mar;23(1):22-35. doi: 10.1177/2053369117699358. Post Reprod Health. 2017. PMID: 28381102 Review. No abstract available.

7

Outcomes of endometrial assessment in women with unscheduled bleeding on hormone replacement therapy.

Abdullahi Idle S, Hamoda H. Abdullahi Idle S, et al. Among authors: hamoda h. Post Reprod Health. 2019 Jun;25(2):95-99. doi: 10.1177/2053369119830822. Epub 2019 Feb 19. Post Reprod Health. 2019. PMID: 30782100 No abstract available.

8

The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women.

Hamoda H, Panay N, Pedder H, Arya R, Savvas M. Hamoda H, et al. Post Reprod Health. 2020 Dec;26(4):181-209. doi: 10.1177/2053369120957514. Epub 2020 Oct 12. Post Reprod Health. 2020. PMID: 33045914 No abstract available.

9

BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020.

Hamoda H, Davis SR, Cano A, Morris E, Davison S, Panay N, Lumsden MA, Hillard T, Simoncini T. Hamoda H, et al. Post Reprod Health. 2021 Mar;27(1):49-55. doi: 10.1177/2053369120983154. Epub 2021 Jan 17. Post Reprod Health. 2021. PMID: 33459135 No abstract available.

10

Experience of hormone replacement therapy in postmenopausal women living with HIV.

Howells P, Modarres M, Samuel M, Taylor C, Hamoda H. Howells P, et al. Among authors: hamoda h. Post Reprod Health. 2019 Jun;25(2):80-85. doi: 10.1177/2053369119838737. Epub 2019 Mar 21. Post Reprod Health. 2019. PMID: 30895862 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page